Serán Featured Guest in Biospace Denatured podcast: The gap is where the pain is: Drug pricing and patient costs
Serán CEO, Dan Smithey participates in this Biospace Denatured podcast to discuss drug development and manufacturing innovations and related complexities surrounding drug pricing, funding and drivers of healthcare costs. This series explores the gap between consumer experience and industry norms.
Host
Lori Ellis, Head of Insights, BioSpace
Guests
Ali Pashazadeh, CEO, Treehill Partners
Dan Smithey, President, CEO and Co-founder, Serán BioScience
Matthew Price, COO and Co-founder, Promontory Therapeutics
Peter Rubin, Executive Director, No Patient Left Behind
Rob Williamson, President and COO, Triumvira Immunologics
Listen on Spotify. Approximate listening time: 20 minutes
Fierce JPM Week Virtual
Jan 22-24, 2025 / Free Virtual Event
The Road Ahead: Pharma, Biotech and Healthcare in a Pivotal Year With a new U.S. president, fresh regulations, and shifting deal trends, 2025 is set to be a transformative year for biopharma and healthcare. At Fierce JPM Week 2025, industry leaders will come together to explore what’s next. From market analysis to an examination of evolving regulatory landscapes, this event will provide expert insights into the opportunities and pressing challenges shaping the future of pharma, biotech, and healthcare.
About Serán
Serán BioScience, LLC, is a science-driven drug development partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, email us at hello@seranbio.com.
Contact
Brinette Holdren
Director of Marketing
Serán BioScience, LLC
63047 Layton Ave,
Bend, OR 97701 USA
Phone: (541)-237-8501
www.seranbio.com